Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-21-068844

Chief Operating Officer acquired 250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lecault Veronique Chief Operating Officer 2021-12-08 Option exercise +250,000 $0.19 $47,500 1,589,333 D
Derivatives
Lecault Veronique Chief Operating Officer 2021-12-08 Option exercise · Share Option (right to buy) −250,000 2,524,134 D
Loading xslF345X03/doc4.xml…